Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials
+News
Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials
Friday 10 July 2020, 03:22 PM
The proposed COVID-19 drug would be inhaled using an inhaler like this.
“The only question is if it’s going to cause side effects – hopefully not as it’s a humanised molecule, but you never know until you do trials”
T
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
References
Iwanaga N, Cooper L, Rong L, et al. Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2. bioRxiv preprint (online 15 June).
https://www.biorxiv.org/content/10.1101/2020.06.15.152157v1.full.pdf
News archive
Class
Hosted Content 2
Why recognising the signs of dehydration is important...
Saturday 1 February 2025, 08:30 AM
2 minutes to Read
Latest issue
